ONCS
It’s now a virtually unknown $1.00 stock
that’s poised to turn $10,000 into $380,000
for one eye-opening reason.
Dear Investor:
I believe that I have uncovered one of America’s most profitable stocks.
Without a doubt, at $1.00 a share, OncoSec Medical, Inc. (Ticker: ONCS) could attract a $38-a-share buyout bid from a pharmaceutical giant.
Once I tell you their extraordinary story, I think you’ll agree.
You see, OncoSec has invented a way that allows a cancer cell to be flooded with a drug called Bleomycin, helping to instantly kill it.
Increasing the Power of BLEOMYCIN 1,728 TIMES By Using Electricity—
An Historic Medical Breakthrough That Can Turn $10,000 Into $380,000 Or More
Remarkably, this new drug delivery technique is done with a small, harmless field of electricity that enhances the cancer cell’s ability to absorb Bleomycin by increasing the permeability of the cancer cell’s surface.
The surface becomes highly porous, absorbing the cancer-killing drug.This use of electricity is called electroporation. And it’s a powerful new weapon against this feared illness.
That’s because the healthy cells are left unharmed. This direct method of “attacking” cancer cells is far superior to putting a drug in your vein where it can kill healthy cells while missing cancerous cells entirely.
THINK ABOUT THAT FOR A MOMENT...
Imagine Buying a Company For Just $1.00 a Share That Could Change The Way We Fight Cancer Forever. Our Profits Could Be Staggering.
But their story gets even better. Before I tell you why, you have to know this.
Surgery for head, neck and cutaneous skin cancers often leave terrible, life- changing scars. Some of them are so bad, people refuse to leave their homes. OncoSec Medical has changed all of this. Using their breakthrough, SURGERY AND SCARRING COULD BECOME OBSOLETE.
paid advertisement, see disclaimer at the bottom
This Breakthrough Can Be as Big As the Discovery of Aspirin.
It Changes Lives and Eliminates Scarring and Painful Surgery
Traditional surgery in these sensitive areas leave scars because surgeons have to “scoop out” surrounding flesh to make sure that they’ve taken out the cancer cells. Think of it as a buffer. Only one problem, it makes you look horrible.
Now imagine when the word gets out on OncoSec Medical’s breakthrough. Wall Street will stand on its head when it hears all of this, believe me.
With OncoSec’s invention, you can now resume your normal daily activities without being stared at or feeling self-conscious because you are not terribly scarred. The benefits are truly astounding. Please consider what this breakthrough offers:
A surgical operation that could have taken up to two hours can now take as little as 15 minutes.
The serious trauma of a surgical operation is eliminated.
This new procedure can cost up to 67% less because patients are in and out of the hospital in record time, a real plus in today’s budget-tightening healthcare atmosphere.
Hospital recovery times of 3 to 6 days is now reduced to 24-48 hours.
Only sick cells are destroyed. The healthy cells are left unharmed.
At $1.00 a Share, OncoSec Medical, Inc. Has the
Potential to Hit $38 a Share Because it’s Turning the Medical
World Upside Down. THIS IS A TRUE BREAKTHROUGH
I’ve given you the big picture, the key reason why this virtually unknown stock can turn into one of the most profitable investments in America. In the next 3 minutes you could change your financial future forever by learning more about this remarkable, little-known enterprise.
OncoSec Medical, Inc. (ONCS) acquired its breakthrough technology from a larger medical company run by one of the industry’s most respected executives, Avtar Dhillon M.D.
The technology was spun off into an independent enterprise with this talented entrepreneur leading the charge precisely because of the enormous value of its business as a stand- alone company.
Management’s plan is to complete the development projects OncoSec (ONCS) is working on and then package the company for a takeover by some multi-billion- dollar pharmaceutical giant in search of the next blockbuster. The profits on this one could be history-making.
OncoSec Has the Potential To Turn
$10,000 into $380,000
Let me give you an idea how rich the rewards are in the medical specialty field. These are companies that were fortunate enough to come up with a better, cheaper, faster way of helping people get healthy.
Here are just a few innovative enterprises that have managed to do something new, making their stockholders rich.
The prices are adjusted for splits and represent the low price to the high price so you can see how high they went. How many of these little-known companies have you heard of?
ATRION Corp—from $4.25 to $164: $5,000 hits $192,941: Atrion develops and makes cardiovascular and fluid delivery devices for U.S. distribution.
Angeion Corporation—from $1.50 to $18: $5,000 grows to $60,000: This booming outfit makes and markets noninvasive cardio respiratory diagnostic systems.
The Cooper Companies—from $5 to $82: $5,000 shoots up to $82,000: Capitalizing on growth in the vision care and women’s healthcare markets worldwide, their stock soared.
ICU Medical—from $3.75 to $49: $5,000 soars to $65,330: Disposable medical connection systems for vascular therapy made this outfit a fortune.
Baxter International—from $6 to $72: $5,000 reaches $59,400: This empire operates in biosciences, medication delivery and renal processes.
Merit Medical Systems—from $2 to $25: $5,000 becomes $62,500: Manufacturing single use medical products for diagnostic procedures worldwide made investors wealthy.
Angeion Corporation—from $1.50 to $18: $5,000 grows to $60,000: This booming outfit makes and markets noninvasive cardio respiratory diagnostic systems.
West Pharmaceutical Services—from $5.50 to $53: $5,000 turns into $48,181: This enterprise makes systems for injectable drug delivery for pharmaceutical healthcare.
paid advertisement, see disclaimer at the bottom
Generating a Mountain of Money Because
Profit Margins are a Staggering 90%!
Upon hearing this next fact for the first time, my reaction was “that does it.” I’ve found what could easily be one of America’s most profitable stocks—AND IT’S JUST $1.00 A SHARE AT THE TIME OF THIS WRITING. Follow this closely. I think you’ll agree with me.
OncoSec Medical, Inc. (ONCS) has invented a way that allows a cancer cell to be flooded with a drug called Bleomycin, helping to instantly kill it.
The best part is, while this drug eradicates the cancerous cells, the healthy cells are left alone. This direct method is far superior to putting it in your vein where its effectiveness is substantially reduced because it’s not close to where the problem is.
This direct method also cuts down on many side-effects because it is placed precisely where the cancer is. It doesn’t have to travel through vital organs to reach the cells. Their story gets even better. Consider...
A Miraculous Use Of Electricity
That Can Save Lives Like Never Before...
It’s a Real Game Changer
Remarkably, this new drug delivery technique is done with a small, harmless field of electricity that enhances the cell’s ability to absorb the drug by increasing the permeability of the cell’s surface. This use of electricity is called electroporation. And it’s a powerful weapon against this illness.
How can they command 90% profit margins? Remember, a 90% profit margin means that on $1 million in sales, they’re earning $900,000 in gross profits. That’s extraordinary by any measure.
They accomplish this with one of the most effective marketing techniques in the world. I call it the razor blade strategy. Here’s how it works.
It Made Gillette Billions Of Dollars—
And It’s Still Working Today...
Remember Gillette, the multi-billion dollar colossus that practically invented modern shaving. They used to give away the basic plastic razor handle FREE. And then they sold the razor blades by the ton to the same customer. It made an absolute fortune because users kept on buying razor blades forever.
That’s exactly what OncoSec Medical, Inc. (ONCS) plans to do. You see, their invention involves two separate parts. The first is a device that generates the electricity. That can be used over and over again by a doctor or hospital.
The second part involves an applicator that looks somewhat like a fork. It is used to apply electrical pulses after the drug is injected into the tumor. This, as you would expect, cannot be used again. Once it does its job on one patient, it has to be discarded and replaced.
It costs the hospital $2,000 per treatment applicator, a very affordable price. And 90% of that is pure profit. This is exactly the strategy that made Gillette one of the great growth stocks making multi-millionaires out of the early investors.
$2,000 is almost nothing compared to other $500,000 to two million dollar plus investments these professionals have to make in other high tech medical equipment in order to stay competitive.
Their Breakthrough Procedure Is In One of the Largest Fields On Earth: Cancer Surgery. It’s Rapidly Growing In America and Around the World
Fortunately, the stigma of cancer is about to be broken down. Consider OncoSec Medical, Inc.’s remarkable procedure that lets patients return to a normal, functioning, productive life. OncoSec Medical, Inc. (ONCS) is currently concentrating on life-enhancing solutions for head, neck and cutaneous skin cancers.
Skin cancers are the most common with almost 3 millionpeoplediagnosed annually.The cost of treating non-melanoma skin cancers run about $1 billion a year, so the need for OncoSec’s solution is enormous.
Skin and neck cancers have a high mortality rate and the number of people afflicted is rising. Every year 100,000 people get these illnesses. But also keep in mind, current therapies can result in life-changing disfigurement.
paid advertisement, see disclaimer at the bottom
The Medical Field Has Changed Forever Thanks to
Two Words: Google It. Patients Are Participating In Their
Treatment More Than EVER Before. This Is Gold For Us!
One of the heaviest uses of the Internet is searching for new, effective and exciting health treatments that can potentially save your life or improve it.
53% said what they found on the Internet made them ask their doctors additional questions. Bottom-line: the Internet is an enormous and influential source of health guidance—and that’s great news for us.
So why is this “gold” for those smart enough to buy OncoSec Medical, Inc. (ONCS) at $1.00 a share? When something new and exciting is developed, overnight millions of people can discover a procedure that normally would be hidden from them.
Can you imagine the demand for OncoSec Medical, Inc.’s breakthrough once word gets out? This is a critical point for you and me as investors. Scarring is one of the greatest fears patients have. This new procedure takes that away. This is a huge development.
Who would choose surgery that results in pain and scarring when they don’t have to? This breakthrough will rank as one of the most innovative, far-reaching procedures ever developed.
People expect progress in medical technology. They see and read about breakthroughs all the time. And once an enterprise develops a better way, they’re very quick to accept it as the new standard.
The Company Sees a Rapidly Growing, Billion Dollar Market That’s Letting Them Reach $250 Million In Sales.
The market for their breakthrough is big, estimated at $1 billion dollars, with $500 million of that being in the U.S. FORBES MAGAZINE says it’s a red hot industry: They report, “Health care and pharmaceutical firms are on the move...” and European markets alone. Every year there are 250,000 new cancer cases in these markets that can use their innovative, safe medical techniques. Remember, that’s 250,000 new cases.
Asia will be an area of major expansion for this one reason that no one can yet explain. Asia has ten times the incidence of certain diseases such as head and neck cancer than that of the western world.
OncoSec (ONCS) also owns a large patent portfolio. This is complimented by endless trade secrets and know-how from years of research and clinical studies. This little-known gem is the world leader in the field of electroporation for treating solid tumors—and they’re just $1.00 a share right now!
Management believes that a sales goal of achieving $250 million in revenue is realistic. And I agree with this because of the uniqueness of their procedure and the undeniable superior benefits it offers over surgery.
There are two other smaller competitors with nowhere near the sophistication or advanced research that OncoSec has created after an investment of $114 million dollars in research and technology the company now employs.
400 People Treated In Clinical
Trials In the U.S. and Europe
OncoSec (ONCS) has accumulated a significant database of patient responses.Their breakthrough has been tested in 11 clinical trials conducted in 13 countries across 83 sites. Human data has been collected from over 400 people with a wide range of cancers. The data shows that it is safe and effective against solid tumors.
The reason why scarring is almost non-existent using their technique is because the following: surgery requires the doctor to remove all the potential cancer cells, including the healthy tissue surrounding the tumor, very much like a buffer zone.
This procedure, in effect, “scoops” out a part of your body that is never restored. It leaves that hollow, disfigured look that no one wants. We’ve all seen it at one time or another.
OncoSec’s (ONCS) breakthrough does not require this buffer to be removed. In fact, since this powerful anti-cancer drug is absorbed by the tumor using electricity. This is a first...and a true breakthrough.
Ask yourself which you would choose.The choice is obvious. And that’s exactly why I’m so optimistic about this stock’s future and its ability to turn $10,000 into $380,000.
paid advertisement, see disclaimer at the bottom
Quality of Life Counts
More Than Ever.
Your Timing Is Perfect...
The healthcare Industry has changed forever. It will never be the same. What counted as standard operating procedure yesterday is outdated today. And for good reason. There will never be a “good old days” view of medical progress.
This is a field where ways of doing things only get better. And I mean much, much better. What was impossible yesterday is commonly accepted today in the blink of an eye.
Imagine if someone said that one day you will be able to “see” inside someone and not have to lay a finger on them to do so. Who would have believed it? Yet today they call it a CAT scan and no one thinks twice about it.
I am convinced that for some procedures we will all look back and view surgery as a backwards way of having done things. It will look like the dark ages—only because we now have such phenomenally great options like OncoSec’s breakthrough.
All This Adds Up to a Stock That You Should Buy.
If You Read About This Enterprise In
You’re Going to Kick Yourself
All great investments start off very quietly. When you look back, you think, “Of course, it’s a great idea. It’s obvious.”That’s how most people later view it—and it’s why most people NEVER TURN $10,000 INTO $380,000. They miss an opportunity to harness the huge earning power of the market and change their financial life forever.
I Can’t Guarantee That I’ll Contact You Again. Don’t Miss Your Chance
My advice is simple: call your discount broker and pick up some OncoSec Medical, Inc. (ONCS) right now at the unbelievably low price it’s now at. This truly is an unknown stock—for now. Remember, you’re buying into the world leader in its industry. Where else can you do that at $1.00 a share?
OncoSec Medical, Inc. (ONCS) right now at the unbelievably low price it’s now at. This truly is an unknown stock—for now. Remember, you’re buying into the world leader in its industry. Where else can you do that at $1.00 a share?
DON’T MISS ONCOSEC MEDICAL, INC. (ONCS) Ask yourself if you would use their services. Since the answer is a clear and resounding yes, this makes my point about their $1.00 stock. It’s a screaming buy that could easily turn $10,000 into $380,000 because their solution is so superior to surgery.
I believe management can build a $250 million dollar business. The rewards of that alone would be enough to retire on. But you can’t participate if you remain on the sidelines. Pick up an amount of stock you’re comfortable with so you’re not left behind when the train pulls out of the station.
Imagine the coverage OncoSec Medical, Inc. (ONCS) will get when millions upon millions of people go to the Internet in search of a better solution for their pending health concerns.
Do it now. You don’t want to regret missing out on this extraordinary once-in-a- lifetime opportunity.
